Managing patient adherence and quality of life in epilepsy

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 1, 2007, Pages 117-131

  Eatock, Joanne ^a   Baker, Gus A ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Adherence; Antiepileptic drugs; Compliance; Epilepsy; QOL

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ACNE; ALCOHOL WITHDRAWAL; ANXIETY; ATTENTION DISTURBANCE; CONCENTRATION LOSS; DEPRESSION; DIZZINESS; DOCTOR PATIENT RELATION; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; EPILEPSY; FAMILY LIFE; FATIGUE; FEEDBACK SYSTEM; GINGIVA DISEASE; HEAD INJURY; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; INDIVIDUALIZATION; LIFESTYLE MODIFICATION; LIVER FAILURE; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; MEMORY DISORDER; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PREDICTION; PRESCRIPTION; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RASH; REVIEW; SELF CARE; SIDE EFFECT; SLEEP TIME; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; STIGMA; STRESS MANAGEMENT; TERATOGENICITY; TOOTH DISEASE; TOOTH INJURY; TREATMENT DURATION; VISUAL IMPAIRMENT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 34249307847     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2007.3.1.117     Document Type: Review

References (80)

1. Anderson GD, Kim H, Warner MH. 2000. Impact of taking antiepileptic drugs at school in a group of children and adolescents. Epilepsy Behav, 1:17-21.
2. Asadi-Pooya AA. 2005. Drug compliance of children and adolescents with epilepsy. Seizure, 14:393-5.
3. Austin JK, Huster GA, Dunn DW, et al. 1996. Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia, 37:1228-38.
4. Baker GA, Jacoby A, Buck D, et al. 1997. Quality of life of people with epilepsy: a European study. Epilepsia, 38:353-62.
5. Barofsky I. 1978. Compliance, adherence and the therapeutic alliance: steps in the development of self-care. Soc Sci Med, 12:369-76.
6. Becker MH, Maiman LA. 1975. Sociobehavioural determinants of compliance with health and medical care recommendations. Med Care, 13:10-23
7. Bishop M, Allen CA. 2003. The impact of epilepsy on quality of life: a qualitative analysis. Epilepsy Behav, 4:226-33.
8. Bissell P, May CR, Noyce PR. 2004. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med, 58:851-62.
9. Bosley CM, Fosbury JA, Cochrane GM. 1995. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J, 8:899-904.
10. Bowling A. 1995. What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life. Soc Sci Med, 41:1447-62.
11. Britten N. 1994. Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract, 44:465-8.
12. van den Broek M, Beghi E for the RESt-1 group. 2004. Accidents in patients with epilepsy: types, circumstances and complications: a European cohort study. Epilepsia, 45:667-72.
13. Bosley CM, Fosbury JA, Cochrane GM. 1995. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J, 8:899-904.
14. Browne TR, Holmes GL. 2004. Handbook of epilepsy. 3rd ed. Philadelphia: Lippincott Williams and Wilkins.
15. Buck D, Baker GA, Jacoby A, et al. 1997a. Patients' experiences of injury as a result of epilepsy. Epilepsia, 38:439-44.
16. Buck D, Jacoby A, Baker GA, et al. 1997b. Factors influencing compliance with antiepileptic drug regimes. Seizure, 6:87-93.
17. Buelow JM, Smith MC. 2004. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav, 5:401-6.
18. Carter S, Taylor D, Levenson R. 2005. A question of choice - compliance in medicine taking a preliminary review. 3rd ed. Medicines Partnership Task Force, Department of Health.
19. Casebeer AL, Verhoef MJ. 1997. Combining qualitative and quantitative methods: considering the possibilities for enhancing the study of chronic diseases. Chronic Dis Can, 18:130-5
20. Chaplin JE, Wester A, Toinson T. 1998. Factors associated with the employment problems of people with established epilepsy. Seizure, 7:299-303.
21. Christensen DB, Williams B, Goldberg HI, et al. 1997. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care, 35:1164-70.
22. Choo PW, Rand CS, Inui TS, et al. 1999. Validation of patient reports, automated pharmacy records and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care, 37:846-57.
23. Claxton AJ, Cramer J, Pierce C. 2001. A systematic review of the Associations between dose regimens and medication compliance. Clin Ther. 23:1296-310.
24. Conrad P. 1985. The meaning of medications: another look at compliance. Soc Sci Med, 20:29-37.
25. Cramer J, Mattson RH, Prevey ML, et al. 1989a. How often is medication taken as prescribed? A novel assessment technique. JAMA, 261:3273-7.
26. Cramer J, Mattson RH, Prevey ML, et al. 1989b. How often is medication taken as prescribed? A novel assessment technique. (Correction) JAMA, 262:1472.
27. Cramer JA, Scheyer RD, Mattson RH. 1990. Compliance declines between clinic visits. Arch Intern Med, 150:1509-10.
28. Cramer J, Vachon L, Desforges C, et al. 1995. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia, 36:1111-17.
29. Cramer J.A, Glassman M, Rienza V. 2002. The relationship between poor medication compliance and seizures. Epilepsy Behav, 3:338-42.
30. Dilorio C, Osborne Shafer P, Letz R, et al and the Project EASE Study Group. 2003. The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav, 4:259-67.
31. Donovan JL, Blake DR. 1992. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med, 34:507-13.
32. Doughty J, Baker G.A, Jacoby A, et al. 2003. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy. Epilepsy Behav, 4:710-16.
33. Duncan JS. 1991. Modern treatment strategies for patients with epilepsy: a review. J R Soc Med, 84:159-62.
34. Epilepsy Action 2006. Epilepsy facts, figures and terminology [online]. Accessed 7th June 2006. URL: www.epilepsy.org.uk.
35. Farmer KC. 1999. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther, 21:1074-90.
36. Feinstein AR. 1990. On white-coat effects and the electronic monitoring of compliance (Editorial). Arch Intern Med, 150:377-8.
37. Ficker DM, Privitera M, Krauss G, et al. 2005. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. Neurology, 65:593-5.
38. Fisher RS, Vickrey BG, Gibson P, et al. 2000. The impact of epilepsy from the patient's perspective II: views about therapy and health care. Epilepsy Res, 41:53-61.
39. Garrity TF. 1981. Medical compliance and the clinician-patient relationship: a review. Soc Sci Med, 15E:215-22.
40. Gilliam F, Kuzniecky R, Faught E, et al. 1997. Patient-validated content of epilepsy-specific quality of life measurement. Epilepsia, 38:233-6.
41. Gomes Mda M, Maia Filho Hde S. 1998. Medication-taking behavior and drug self regulation in people with epilepsy (English translation). Arq Neuropsiquiatr, 56:714-19
42. Gopinath B, Radhakrishnan K, Sankara Sarma P, et al. 2000. A questionnaire survey about doctor-patient communication, compliance and locus of control among South Indian people with epilepsy. Epilepsy Res, 39:73-82.
43. Hayden M, Penna C, Buchanan N. 1992. Epilepsy: patient perceptions of their condition. Seizure, 1: 191-7.
44. Helde G, Bovim G, Brathen G, et al. 2005. A structured, nurse led intervention program improves quality of life in patients with epilepsy: A randomized, controlled trial. Epilepsy Behav, 7:451-7.
45. Jacoby A, Gorry J, Baker GA. 2005. Employers' attitudes to employment of people with epilepsy: still the same old story? Epilepsia, 46:1978-87.
46. Jacoby A, Baker GA. 2000. The problem of epilepsy. In Baker GA, Jacoby A (eds). Quality of life in epilepsy: beyond seizure counts in assessment and treatment. London: Harwood Academic.
47. Jacoby A. 1992. Epilepsy and the quality of everyday life findings from a study of people with well-controlled epilepsy. Soc Sci Med, 34:657-66.
48. Jones RM, Butler JA, Thomas VA, et al. 2006. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure. In press.
49. Kirby S, Sadler RM. 1995. Injury and death as a result of seizures. Epilepsia, 36:25-8.
50. Kobau R, Dilorio C. 2003. Epilepsy self-management: a comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviours among people with epilepsy. Epilepsy Behav, 4:217-25.
51. Kruse W, Eggert-Kruse W, Rampmaier J, et al. 1991. Dosage frequency anddrug-compliance behaviour - a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol, 41:589-92.
52. Kyngas H. 2000. Compliance with health regimens of adolescents with epilepsy. Seizure, 9:598-604.
53. Kyngas H. 2001. Predictors of good compliance in adolescents with epilepsy. Seizure, 10:549-53.
54. Lawn ND, Bamlet WR, Radhakrishnan K, et al. 2004. Injuries due to seizures in persons with epilepsy: a population-based study. Neurology, 63:1565-70.
55. Leidy NK, Elixhauser A, Vickrey B, et al. 1999. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology, 53:162-6.
56. Marinker M, Shaw J. 2003. Not to be taken as directed, putting concordance for taking medicines into practice. BMJ, 326:348-9.
57. McGraw C. 2004. Multi-compartment medication devices and patient compliance. Br J Community Nurs, 9:285-90.
58. Mitchell WG, Scheier LM, Baker SA. 2000. Adherence to treatment in children with epilepsy: who follows "doctor's orders"? Epilepsia, 41:1616-25.
59. MRC AEDWS (Medical Research Council Antiepileptic Drug Withdrawal Study Group); Jacoby A, Johnson A, Chadwick 1992. Psychosocial outcomes of antiepileptic drug discontinuation. Epilepsia, 33:1123-31.
60. Mullen PD. 1997. Compliance becomes concordance (Editorial). BMJ, 314:691.
61. Osterberg L, Blaschke T. 2005. Adherence to medication. N Engl J Med, 353:487-97.
62. Paes AHP, Bakker A, Soe-Agnie CJ. 1997. Impact of dosage frequency on patient compliance. Diabetes Care, 20:1512-17.
63. Perucca E, Meador KJ. 2005. Adverse effects of antiepileptic drugs. Acta Neurol Scand, 112(Suppl 181):30-5.
64. Ratsepp M, Haldre OA, Kaasik, A. 2000. Felt stigma and impact of epilepsy on employment status among Estonian people: exploratory study. Seizure, 9:394-401.
65. Read T, Mijch A, Fairley KC. 2003. Adherence to antiretroviral therapy: are we doing enough? Intern Med J, 33:254-6.
66. Sander J. W. 2004. The use of antiepileptic drugs - principles and practice. Epilepsia, 45(Suppl 6):28-34.
67. Sander JW 2005. Ultimate success in epilepsy - the patient's perspective. Eur J Neurol, 12(Suppl):3-11.
68. Schachter SC. 1999. Antiepileptic drug therapy: general treatment principles and application for special patient populations. Epilepsia, 40(Suppl 9):S20-5.
69. Schroeder K, Fahey T, Hay AD, et al. 2006. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol, 59:650-1.
70. Shope JT. 1988. Compliance in children and adults: review of studies. Epilepsy Res, 29(Suppl 1):23-47.
71. Specht U, Elsner H, May T.W, Schimichowski B and Thorbecke R. 2003. Postictal serum levels of antiepileptic drugs for detection of non-compliance. Epilepsy Behav, 4:487-95.
72. Steiner JF, Prochazka AV. 1997. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol, 50:105-16.
73. Tashkin DP. 1995. Multiple dose regimens. Impact on compliance. Chest, 107:176-182.
74. Trostle JA. 1988. Medical compliance as an ideology. Soc Sci Med, 271299-309.
75. Vermeire E, Hearnshaw H, Van Royen P et al. 200 1. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther, 26:331-42.
76. Walters RJL, Hutchings AD, Smith DF, etal. 2004, Inappropriate requests for serum anti-epileptic drug levels in hospital practice. Q J Med, 97:337-41.
77. Wheless JW 2006. Intractable epilepsy: a survey of patients andcaregivers. Epilepsy Behav, 8:756-64.
78. Williams J, Patsalos PN, Wilson JF. 1997. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. Forensic Sci Int, 84:113-22.
79. World Health Organization. 1997. WHOQOL Measuring quality of life. Division of Mental Health and prevention of substance abuse. Geneva: WHO.
80. Yeager KA, Dilorio C, Osborne Shafer P, et al. 2005. The complexity of treatments for persons with epilepsy. Epilepsy Behav, 7:679-86.